EGY — VAALCO Energy, Inc. · 2026-09-06 · Verdict: PASS · Conviction 3

Price $6.00 (screen row, universe_under2b.csv, 2026-09-06 run; no live prices available here) · Mkt cap $631M · EV $778M (screen) / ~$910M incl. finance leases and ARO · EV/EBIT n/m (FY2025 EBIT −$20.6M) · FCF yield: screen 33.7%, actual FY2025 −6.4% · Net debt $146.6M · ADV $7.2M Sources read: 10-K 2026-03-16 (Items 1, 1A, 7), 10-Q 2026-08-10 (MD&A), DEF 14A 2026-04-24, 8-Ks 2026-03-12, 2026-05-07, 2026-08-06 (Item 2.02 / EX-99.1), Form 4s (12m). No transcript or prepared remarks were filed as an exhibit, so Section 5 uses guidance tables rather than call commentary.

1. What the business actually does

Vaalco produces crude oil under African production sharing contracts: the operated Etame Marin block offshore Gabon, a 100% working interest joint venture in Egypt's Merged Concession and South Ghazalat, a 27.4% non-operated interest in the deepwater Baobab field on Block CI-40 offshore Côte d'Ivoire, undeveloped Block P (Equatorial Guinea) and a non-producing Nigerian discovery (10-K 2025, Item 1). Canada was sold in February 2026 for $25.5 million. Q2 2026 production was 21,796 WI and 16,688 NRI BOEPD. Contract lives are near: Etame runs to 2028 with two five-year options, Egypt's Merged Concession to 2035 with South Ghazalat expiring 2027, CI-40 to 2038, and the Gabon carried working interest rose from 7.5% to 10% on June 20, 2026.

2. Why it is mispriced: the edge case

Triage flagged cyclical-trough and the trailing numbers look like one: FY2025 EBIT was −$20.6 million on a year-long Baobab FPSO dry dock and a $67.2 million impairment of the Canadian assets held for sale (10-K 2025, Item 7), and Baobab restarted in June 2026 with Q2 Adjusted EBITDAX of $54.8 million against $11.6 million in Q1 (Q2 2026 8-K).

There is no mispricing here. The trough is in the reported earnings, not the price: the stock sits 8.1% below its 52-week high with 12-1 momentum of +36.5% (screen row), so no one is a forced or indifferent seller and the restart is already marked. Two screen artefacts do the work the edge case should. The 33.7% FCF yield exists only because capex was untagged and treated as zero: FY2025 operating cash flow of $212.7 million against $252.9 million of cash capex is real free cash flow of −$40.2 million (8-K 2026-03-12), and the blank EV/EBIT hides a negative FY2025 EBIT.

3. Unit economics

Q2 2026 is the cleanest look and it is unflattering. Brent averaged $102.63, the highest print in these filings; Vaalco realized $80.77 per BOE before hedges and $65.34 after, against production expense of $28.05, DD&A of $21.14 and G&A of $6.91 per BOE. GAAP net income of $42.4 million looks strong, but management's own Adjusted Net Income, stripping the $43.7 million unrealized derivative gain and deferred tax, was a loss of $0.3 million in Q2 and a $47.4 million loss for H1 (Q2 2026 8-K, non-GAAP reconciliation). At the best oil price in the dataset, this company earned nothing. The hedge book is why: H2 2026 collars cover 1,469,000 barrels at ceilings near $68.50, Q2 carried a $25.0 million realized hedge loss, and the RBL requires hedging (10-Q Q2 2026, MD&A).

Reserves are the second issue: proved was 43.0 MMBOE at YE2025, down 5%, on a 66% reserve replacement ratio (8-K 2026-03-12). Ex-Canada that is about 36.8 MMBOE against 5.8 MMBOE of annual NRI production, a six-year life, and 25.5 MMBOE of it is undeveloped, 18.2 MMBOE in Côte d'Ivoire.

4. Balance sheet and capital allocation

Net debt went from $1.1 million at YE2025 to $146.6 million at June 30, 2026. Cash is $30.4 million with about $123.0 million undrawn on a $300.0 million RBL whose commitments step down $15.8 million in March 2027 and $35.5 million each half-year after. H1 capex of $181.6 million against $34.5 million of operating cash flow is free cash flow of −$147.2 million, funded by borrowings plus the Canada sale, against FY2026 capex guidance of $290-360 million (Q2 2026 8-K). Management's published "Free Cash Flow" of −$15.1 million adds financing inflows back in and should be ignored. The $0.0625 quarterly dividend, about $27 million a year, is funded with borrowed money. Insiders own 3.0% and BlackRock 7.2%; trailing-12m Form 4 activity is 15 tax-withholding dispositions and 2 grants, with no open-market buys.

5. Management: said versus did

Operationally they deliver. FY2026 NRI production guidance went from 16,100-17,950 BOEPD in March to 17,400-19,450 in May to 17,500-19,400 in August with capex held at $290-360 million throughout, and Q2 capex of $103.6 million came in below the $110-130 million range. The gap is between operational delivery and cash. The FY2026 sales midpoint of 18,575 NRI BOPD needs H2 volumes near 22,100 BOPD when Q3 is guided to 17,200-18,900, so Q4 must reach roughly 26,000 BOPD: the low end is reachable, the midpoint is back-end loaded.

6. Valuation

Base (45%): Brent $80, 2027 sales 7.5 MMBOE at a $20 per BOE cash margin, about $150 million operating cash against $180 million capex, so break-even. 4.0x $190 million EBITDAX less $250 million net debt is $4.85. Bear (30%): Brent $65, near the collar floors. Cash margin near $10 per BOE, capex commitments continue, dividend cut, probable equity issuance. 3.5x $120 million EBITDAX less $300 million net debt is $1.15. Bull (25%): Brent near $100, Baobab Phase Five and Egypt deliver, 2027 sales 9 MMBOE at $30 per BOE, capex falls to $150 million. 4.5x $300 million EBITDAX less $200 million net debt is $11.00. Probability weighted: $5.28 against $6.00.

Reverse DCF: at $6.00 the screen EV of $778 million, or roughly $910 million including $50.8 million of noncurrent finance leases and $81.6 million of ARO, implies about $95 to $110 million of sustained annual free cash flow discounted at 10% over the remaining contract lives, against H1 2026 free cash flow of −$147.2 million. The audited standardized measure was $410.0 million at YE2025, $382.2 million ex-Canada (10-K 2025, Item 1), so the price is twice the proved-reserve floor and the undeveloped book is already in the quote.

7. Catalysts

First Côte d'Ivoire lifting August 2026; Baobab Phase Five drilling from September 2026; Block P Venus FID expected Q4 2026; Kossipo development plan H1 2027; new Gabonese Oil and Gas Codes expected Q3 2026; Q3 results in November with the first read on 2027 capex.

8. Risks and pre-registered kill criteria

Chief risks: the oil price, the funding gap, and Gabonese fiscal terms (a new Oil and Gas Code is due). Kill criteria: 1. Two consecutive quarters of positive Adjusted Net Income with realized prices including hedges above $70 per BOE. 2. FY2027 capital guidance at or below $200 million alongside NRI sales above 20,000 BOPD. 3. Net debt above $250 million at any quarter end, or a dividend cut or suspension. 4. Q4 2026 NRI sales below 20,000 BOPD, meaning the FY2026 sales midpoint was missed.

9. Verdict and summary

PASS, conviction 3. Vaalco is an operationally competent African E&P: it raised production guidance twice this year without raising capex and restarted Baobab on schedule. But it is not a cyclical-trough purchase at $6.00: the trough is in the trailing earnings, not the price, which sits 8% off its 52-week high after a 36% twelve-month run. The decisive fact: in Q2 2026, with Brent averaging $102.63, the company's own Adjusted Net Income was a loss of $0.3 million, while H1 free cash flow was negative $147 million and net debt went from $1.1 million to $146.6 million in six months. With capex guided to $290-360 million against $30.4 million of cash, a dividend funded by borrowings and a six-year proved reserve life, this is a spending year priced as though the harvest year were banked.

Research for discussion, not investment advice. Positions and sizing are the reader's decision.